Global Fill-finish Manufacturing Market Is Expected to Reach USD 14.81 billion by 2027 : Fior Markets
15 sept. 2020 19h00 HE
|
Fior Markets
Newark, NJ, Sept. 15, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global fill-finish manufacturing market is expected to grow from USD 6.81 billion in 2019 and to reach...
Trevi Therapeutics to Present at H.C. Wainwright Global Investment Conference
09 sept. 2020 16h05 HE
|
Trevi Therapeutics
NEW HAVEN, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™...
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery
09 sept. 2020 08h30 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Aeterna Zentaris to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
09 sept. 2020 08h00 HE
|
Aeterna Zentaris Inc
- Live video webcast with CEO, Dr. Klaus Paulini, on Wednesday, September 16th at 11:00 AM EDT - CHARLESTON, S.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:...
Inato Announces the Participation of Over 300 Clinical Trial Research Sites in its Global Marketplace
09 sept. 2020 08h00 HE
|
Inato SAS
PARIS, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Inato, the first global industry marketplace that matches research sites to the right clinical trial protocols, today announced key growth milestones for...
Monthly information on share capital and company voting rights
07 sept. 2020 16h30 HE
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, Sept. 07, 2020 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 ...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07 sept. 2020 16h30 HE
|
Cellectis Inc.
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) NEW YORK, 07 sept. 2020 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth Code ISIN : FR0010425595 DateNombre...
Biofrontera report results for the first six months of 2020
26 août 2020 09h51 HE
|
Biofrontera AG
Leverkusen, Germany, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today published its...
Trevi Therapeutics Announces Second Quarter 2020 Financial Results and Business Update
13 août 2020 16h05 HE
|
Trevi Therapeutics
Announced Positive Outcome of Sample Size Re-Estimation Analysis for PRISM Trial Strong Enrollment in PRISM Trial After Lifting of COVID-19 Restrictions Announces $14 Million Term Loan - Cash...
RedHill Biopharma Provides Q2/2020 Financial Results and Operational Highlights
13 août 2020 07h00 HE
|
RedHill Biopharma Ltd.
Q2/2020 net revenues of approximately $21 million, up from $1.1 million in Q1/2020 and $1.6 million in Q2/2019, an increase of approximately 1,900% and 1,200%, respectively -- Completed...